| Literature DB >> 27531365 |
Zhi-Hua Wang1, Xin-Min Li2, Yu-Shui Wang3, Ze-Yang Guo3.
Abstract
As previous study showed that Mycoplasma pneumoniae (MP) induced a cellular immune response associated with interleukin-17 (IL-17), we designed this study to explore IL-17 in MP pneumonia patients with atopic sensitization and 144 patients were evaluated and divided into three groups: atopic MP pneumonia group (n = 38), non-atopic MP pneumonia group (n = 74), and atopic non-MP pneumonia group (n = 32). Serum IL-17 was measured at admission acute phase and at recovery phase. We found IL-17 levels only in the atopic MP pneumonia group that were significantly higher at recovery phase than at acute phase, and its levels were also higher in the atopic MP pneumonia group than the other two groups at clinical recovery phase. In addition, acute asthma attack was higher in the atopic MP pneumonia group. Therefore, IL-17 should be related with asthma and it can be a good marker warning an acute asthma attack in atopic MP pneumonia. Necessary measures can be taken as prevention.Entities:
Keywords: Mycoplasma pneumoniae pneumonia; asthma; atopy; interleukin-17
Mesh：
Substances：
Year: 2016 PMID： 27531365 DOI： 10.1007/s10753-016-0422-3
Source DB: PubMed Journal: Inflammation ISSN： 0360-3997 Impact factor: 4.092